Enzyl 160mg Tablet

About Enzyl 160mg Tablet

Enzyl 160mg Tablet contains Enzalutamide, a targeted anticancer medication that belongs to the androgen receptor inhibitor class and is used in the treatment of advanced prostate cancer in adult men whose disease no longer responds adequately to surgical or hormonal therapies. It works by blocking the action of androgens (male hormones) that stimulate the growth and spread of prostate cancer cells, helping to slow disease progression and improve treatment outcomes. Patients should not take Enzyl 160mg Tablet if they are allergic to Enzalutamide or any of its ingredients. During treatment, healthcare providers may regularly monitor prostate-specific antigen (PSA) levels, liver function tests, and complete blood counts (CBC) to evaluate treatment response and detect potential side effects early. Patients with a history of seizures should use this medication with caution, as Enzalutamide may increase the risk of seizure activity. Grapefruit and grapefruit juice should be avoided during treatment because they can increase the concentration of the medication in the body and raise the risk of side effects. This medicine may cause harm to an unborn baby and can also affect fertility; therefore, patients should discuss fertility preservation and family planning options with their healthcare provider before starting therapy. Effective contraception is recommended for both men and women during treatment and for at least three months after the final dose. Regular medical monitoring and adherence to prescribed therapy are essential to ensure the safe and effective use of Enzyl 160mg Tablet in the management of advanced prostate cancer and to achieve the best possible treatment outcomes.